YZ-35
YZ-35 is a STAT3 inhibitor, with a Ki value of 0.38 μM. YZ-35 binds directly to STAT3 with high affinity, exhibiting a dissociation constant (Kd) of 190 nM. YZ-35 directly attenuates the dual phosphorylation of STAT3 (Tyr705 and Ser727). YZ-35 suppresses colony formation, cellular migration, and induces apoptosis in breast cancer cell lines (BCSC). YZ-35 selectively suppresses BCSC self-renewal. YZ-35 inhibits tumor growth in the BCSC xenograft models. YZ-35 can be used for the study of breast cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C29H24N2O5S
- 分子量:512.58
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
YZ-35 (0.1-100 μM, 48 h) demonstrates inhibitory potency against MDA-MB-231 cells (IC50 = 0.63 μM), MCF-7 cells (IC50 = 0.32 μM) and MCF-10A cells (IC50 = 34.34 μM)[1]. YZ-35 (0-4 μM, 0-48 h) directly attenuates the dual phosphorylation of STAT3 (Tyr705 and Ser727) to exhibit potent anti-breast cancer efficacy efficacy in MDA-MB-231 and MCF-7 cells[1]. YZ-35 (0-6 μM, 24-48 h) suppresses colony formation, cellular migration, and induces apoptosis in MDA-MB-231 and MCF-7 cells[1]. YZ-35 (2.5-10 μM, 48 h) reduces tumor stemness in MDA-MB-231 and MCF-7 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MDA-MB-231 cells, MCF-7 cells and MCF-10A cells
-
Concentration:0.1-100 μM
-
Incubation Time:48 h
-
Result:Demonstrated inhibitory potency against MDA-MB-231 cells (IC50 = 0.63 μM), MCF-7 cells (IC50 = 0.32 μM) and MCF-10A cells (IC50 = 34.34 μM).
-
Cell Line:MDA-MB-231 cells and MCF-7 cells
-
Concentration:0, 1, 2, 3, 4 μM
-
Incubation Time:0, 12, 24, 36, 48 h
-
Result:Exhibited concentration- and time-dependent suppression of the phosphorylation of STAT3 at both Tyr705 and Ser727 residues in MDA-MB-231 and MCF-7 cell lines, while maintaining total STAT3 protein levels. Showed no effect on the expression levels of STAT1 and STAT5 or their phosphorylation.
Did not impact the phosphorylation of JAK2, Src, and ERK. Inhibited the expression of critical apoptosis-related proteins, including Cyclin D1, BCL2, BCL-xL, and Survivin, in a concentration-dependent manner.
-
Cell Line:MDA-MB-231 cells and MCF-7 cells
-
Concentration:0, 1, 2, 3 μM
-
Incubation Time:24 h
-
Result:Decreased the migration of MDA-MB-231 cells by 99%. Reduced the migration in MCF-7 cells by 72.97%.
-
Cell Line:MDA-MB-231 cells and MCF-7 cells
-
Concentration:0, 1, 2, 4, 6 μM
-
Incubation Time:48 h
-
Result:Induced programmed cell apoptosis in a concentration-dependent manner, with differential responses observed between BRCA subtypes: predominantly late-stage apoptosis in MDA-MB-231 cells, while promoting both earlyand late-phase apoptotic events in MCF-7 cells.
-
Cell Line:MDA-MB-231 cells and MCF-7 cells
-
Concentration:0, 1, 2, 3 μM
-
Incubation Time:48 h
-
Result:Induced programmed cell death of BRCA, notably manifesting as pronounced chromatin condensation and nuclear fragmentation, with the most substantial apoptotic phenotype observed at 3 μM concentration.
| Species | Dose | Route | AUC0-t | AUC0-∞ | T1/2 | MRT0-∞ | Vd/F | CL |
|---|---|---|---|---|---|---|---|---|
| Mice[1] | 10 mg/kg | i.v. | 6637.79 ng·h/mL | 7213.53 ng·h/mL | 16.03 h | 9.92 h | 31.01 L/kg | 1.41 L/h/kg |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:1 × 107 MDA-MB-21 cells were resuspended with 100 μL saline and injected into the left flank of 5-week-old female BALB/c-nude mice[1]
-
Dosage:5, 10 mg/kg
-
Administration:i.v. once daily for 21 days
-
Result:Inhibited tumor growth (the TGI of high (10 mg/kg) and low (5 mg/kg) groups were 89.98 and 74.13%, respectively). Inhibited STAT3 phosphorylation and significantly reduced FOXM1 and AURKA expression. Augmented the proportion of apoptotic cells while concurrently diminishing Ki67-positive proliferating cell populations in tumor tissues relative to vehicle controls. Showed no significant toxicity was observed in major organs including the heart, liver, spleen, lung, and kidney.
化学情報
-
分子量 512.58
-
分子式 C29H24N2O5S
-
SMILES
O=C(CC1=CC2=C(C=CC=C2)N1)NCC(C3=O)=C(C(C4=C3C=CC=C4OC)=O)SC5=CC=C(C=C5)OC
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
YZ-35 関連分類
HY-175253 関連分類
Powered by Bioz